Prospective observational study for exploring biomarkers predictive for clinical efficacy of bronchial thermoplasty in patients with bronchial asthma
Not Applicable
- Conditions
- Bronchial asthma
- Registration Number
- JPRN-UMIN000026176
- Lead Sponsor
- Gunma University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 3
Inclusion Criteria
Not provided
Exclusion Criteria
1) Implantation of an internal or external pacemaker or internal cardiac defibrillator 2) Known sensitivity to medications required to perform bronchoscopy, including lidocaine, atropine and benzodiazepines 3) lower respiratory tract infection 4) Unstable asthma with an increased does of systemic corticosteroids within 2 weeks 5) Known coagulopathy 6) As with other bronchoscopic procedures, patients should stop taking anticoagulants, antiplatelet agents, aspirin, and NSAIDs before the procedure with physician guidance 7) Any other condition, which in the opinion of the investigator would preclude participation in the study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Exploring biomarkers of bronchial thermoplasty in bronchial asthma by the method of omics approach
- Secondary Outcome Measures
Name Time Method nexpected visits and admission for exacerbation of bronchial asthma Change of bronchial asthma related quality of life, spirometry parameters and fractional exhaled nitric oxide